75A50126C00007↗

Name: 75A50126C00007: Advance the Development of Scy-247, a Novel Antifungal Currently in Phase 1 Clinical Trials, for the Treatment of Invasive Candidiasis and Prophylaxis of Invasive Fungal Disease As Oral and Ic Formula
Creator: SpendQuery
License: https://www.usa.gov/government-works

ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA

Definitive Contract · Office of Assistant Secretary for Preparedness and Response · to Scynexis Inc (UEI H6PSJYEW3DT9) · data as of 2026-10-22

Obligated to date$18.45M1 action

Current value$18.45Mwith options exercised

Potential value$213.94Mif every option is used

Period2026-09-15 → 2032-07-31current end date

What it is

Product or service: Health R&D Services; Health Care Services; Experimental Development (PSC AN13)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition: Full and open competition · 1 offer received
Pricing: Cost no fee
How it was bought: Standalone contract
Solicitation: BAA-23-100-SOL-00004
Where the work is: Hudson, NJ · district NJ-08

Obligations by fiscal year

FY2026$18.45M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-09-25. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-25	0		$18.45M	ADVANCE THE DEVELOPMENT OF SCY-247, A NOVEL ANTIFUNGAL CURRENTLY IN PHASE 1 CLINICAL TRIALS, FOR THE TREATMENT OF INVASIVE CANDIDIASIS AND PROPHYLAXIS OF INVASIVE FUNGAL DISEASE AS ORAL AND IC FORMULA

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…